Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
36.9M
-
Shares change
-
-1.85M
-
Total reported value, excl. options
-
$84.1M
-
Value change
-
-$5.05M
-
Number of buys
-
38
-
Number of sells
-
-36
-
Price
-
$2.28
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q1 2020
85 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q1 2020.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.9M shares
.
Largest 10 shareholders include NEA Management Company, LLC (9.09M shares), BVF INC/IL (7.36M shares), WELLINGTON MANAGEMENT GROUP LLP (4.83M shares), Camber Capital Management LP (3.5M shares), Invesco Ltd. (2.39M shares), VANGUARD GROUP INC (1.75M shares), DIMENSIONAL FUND ADVISORS LP (1.18M shares), STATE STREET CORP (623K shares), GEODE CAPITAL MANAGEMENT, LLC (517K shares), and MORGAN STANLEY (480K shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.